Meena Seshamani
Showing 1–2 of 2 transcripts.
- Milken Institute20 min
A Conversation with CMS Director of Medicare Meena Seshamani | Future of Health Summit 2024
Meena Seshamani, Bertha Coombs
A multidisciplinary team comprising experts from drug pricing, pharmacy, and economics has implemented health care reforms focused on treating developmental issues, chronic illnesses, and behavioral health within the Medicare and Medicaid systems. These initiatives, which include updating risk adjustment methodologies and navigating the Inflation Reduction Act, aim to reduce prescription drug costs for seniors and integrate services to address over 400,000 additional conditions. With a target deadline of September 1st for international financial agreements, the organization plans to execute these changes over five to eight months while utilizing new communication platforms and patient feedback to ensure system stability.
- Milken Institute1h 1m
Prevention and Innovation for a Healthier Tomorrow | Global Conference 2024
Esther Krofah, Robert Bradway, David Feinberg, Karen Knudsen, Meena Seshamani
Representatives from CMS, the American Cancer Society, Oracle Health, and Amgen convened to address the U.S. healthcare system's inefficiencies, noting that while the sector consumes 20% of GDP, chronic disease prevalence and administrative friction continue to drive costs while outcomes remain misaligned. Key strategies outlined include shifting Medicare toward value-based care with a $2,000 prescription cap, leveraging AI tools like the Oracle Digital Clinical Assistant to reduce physician administrative burdens, and advocating for federal reimbursement of multi-cancer early detection to improve survival rates. The panelists reached a consensus that the current fragmented structure is impoding and requires fundamental structural reforms rather than incremental solutions to successfully integrate prevention, innovation, and data interoperability.